Freenome Holdings, Inc. announced that it has received $254 million in a round of funding led by new investor Roche Holding AG on February 15, 2024. The transaction included participation from new investors a16z Life Sciences Growth Fund, BrightEdge LLC, Cormorant-Capital, Quest Diagnostics Incorporated, Squarepoint Capital returning investors ARK Investments, ArrowMark Colorado Holdings, LLC, ARTIS Ventures, Bain Capital Life Sciences Investors, LLC, DCVC, Eventide Asset Management, LLC, Intermountain Ventures, Perceptive Advisors LLC, Polaris Venture Partners, Inc., Pura Vida Investments, LLC, RA Capital Management, L.P., Sands Capital Ventures, LLC, Section 32, LLC, and accounts advised by T. Rowe Price Group, Inc., with funds and others.